RecallRadar

FDA Drug recall D-0676-2017

Nystatin and Triamcinolone Acetonide Cream, USP, 100,000 USP nystatin units and 1 mg triamcinolone acetonide, distributed in a) 15 grams (N…

On 2017-04-26 the FDA classified a Class II recall of Nystatin and Triamcinolone Acetonide Cream, USP, 100,000 USP nystatin units and 1 mg triamcinolone acetonide, distributed in a) 15 grams (N… by Taro Pharmaceuticals U, citing failed Content Uniformity Specifications; out-of-specification (OOS) results 18-month stability.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0676-2017
ClassificationClass II
Statusterminated
Initiated2017-03-28
Published2017-04-26
Last updated2026-09-13 11:51 UTC
CompanyTaro Pharmaceuticals U
DistributionUS

Product

Nystatin and Triamcinolone Acetonide Cream, USP, 100,000 USP nystatin units and 1 mg triamcinolone acetonide, distributed in a) 15 grams (NDC 51672-1263-1), b) 30 grams (NDC 51672-1263-2) and c) 60 grams (NDC 51672-1263-3) tubes, Rx only, TARO label; Mfd. by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1 -- Dist. by: Taro Pharmaceuticals U.S.A. Inc., Hawthorne, NY 10532

Reason

Failed Content Uniformity Specifications; out-of-specification (OOS) results 18-month stability

Identifiers

ndc51672-1272-1
ndc51672-1272-2
ndc51672-1272-3
ndc51672-1263-1
ndc51672-1263-2
ndc51672-1263-3
code_info
a) 15 g: Lot B505118501, exp. date January 2018; b) 30 g: Lot B504918500, exp. date January 2018; c) 60 g: Lots: I41…a) 15 g: Lot B505118501, exp. date January 2018; b) 30 g: Lot B504918500, exp. date January 2018; c) 60 g: Lots: I416616979, exp. date August 2017, I416716979, exp. date August 2017 and D504519119, exp. date March 2018

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0676-2017%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.